Market Might Still Lack Some Conviction On Shield Therapeutics plc (LON:STX) Even After 35% Share Price Boost
May 22
U.K. (FTSE) Pharma Industry Analysis
UpdatedMay 22, 2024
DataAggregated Company Financials
Companies22
- 7D-0.3%
- 3M17.1%
- 1Y7.6%
- YTD15.5%
In the last week, the Pharma industry is flat overall, with GSK standing out by going down 3.1%. As for the the longer term, the industry is up 7.6% over the past 12 months. Earnings are forecast to grow by 14% annually.
Industry Valuation and Performance
Has the U.K. Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 23 May 2024 | UK£271.2b | UK£71.5b | UK£9.6b | 33.9x | 28.3x | 3.8x |
| Sat, 20 Apr 2024 | UK£243.1b | UK£71.4b | UK£9.8b | 31.9x | 24.9x | 3.4x |
| Mon, 18 Mar 2024 | UK£236.0b | UK£70.4b | UK£9.7b | 32.3x | 24.3x | 3.4x |
| Wed, 14 Feb 2024 | UK£222.6b | UK£69.8b | UK£9.6b | 34.4x | 23.1x | 3.2x |
| Fri, 12 Jan 2024 | UK£243.0b | UK£68.7b | UK£10.7b | 36.8x | 22.8x | 3.5x |
| Sun, 10 Dec 2023 | UK£226.9b | UK£69.4b | UK£10.7b | 33.4x | 21.1x | 3.3x |
| Tue, 07 Nov 2023 | UK£230.3b | UK£70.3b | UK£11.0b | 53.4x | 21x | 3.3x |
| Thu, 05 Oct 2023 | UK£244.4b | UK£70.7b | UK£10.4b | 74.9x | 23.4x | 3.5x |
| Sat, 02 Sep 2023 | UK£236.9b | UK£69.4b | UK£10.2b | 53.5x | 23.2x | 3.4x |
| Mon, 31 Jul 2023 | UK£241.7b | UK£68.1b | UK£9.9b | 52.3x | 24.5x | 3.5x |
| Wed, 28 Jun 2023 | UK£245.8b | UK£67.7b | UK£7.9b | 55.5x | 31.2x | 3.6x |
| Fri, 26 May 2023 | UK£252.4b | UK£68.8b | UK£8.0b | 55.7x | 31.6x | 3.7x |
| Sun, 23 Apr 2023 | UK£262.0b | UK£69.2b | UK£6.9b | 63.2x | 38.2x | 3.8x |
| Tue, 21 Mar 2023 | UK£235.7b | UK£69.7b | UK£6.9b | 44.3x | 34.1x | 3.4x |
| Thu, 16 Feb 2023 | UK£251.2b | UK£70.5b | UK£7.4b | 41.6x | 34x | 3.6x |
| Sat, 14 Jan 2023 | UK£252.3b | UK£79.7b | UK£6.3b | 39x | 39.9x | 3.2x |
| Mon, 12 Dec 2022 | UK£247.0b | UK£79.4b | UK£6.3b | 36.1x | 39.2x | 3.1x |
| Wed, 09 Nov 2022 | UK£231.4b | UK£81.3b | UK£3.6b | 20.8x | 64.8x | 2.8x |
| Fri, 07 Oct 2022 | UK£216.3b | UK£81.1b | UK£3.7b | 19.8x | 59.2x | 2.7x |
| Sun, 04 Sep 2022 | UK£231.4b | UK£79.6b | UK£3.7b | 15x | 62.3x | 2.9x |
| Tue, 02 Aug 2022 | UK£248.1b | UK£77.2b | UK£3.9b | 16.4x | 63.9x | 3.2x |
| Thu, 30 Jun 2022 | UK£275.0b | UK£74.9b | UK£4.6b | 16.8x | 60.3x | 3.7x |
| Sat, 28 May 2022 | UK£264.6b | UK£73.4b | UK£4.6b | 17.2x | 57.7x | 3.6x |
| Mon, 25 Apr 2022 | UK£262.3b | UK£67.2b | UK£4.8b | 20.1x | 54.5x | 3.9x |
| Wed, 23 Mar 2022 | UK£246.4b | UK£66.4b | UK£4.7b | 27.1x | 52x | 3.7x |
| Fri, 18 Feb 2022 | UK£234.4b | UK£65.3b | UK£4.7b | 31.3x | 49.9x | 3.6x |
| Sun, 16 Jan 2022 | UK£232.2b | UK£61.0b | UK£5.6b | 30.7x | 41.3x | 3.8x |
| Tue, 14 Dec 2021 | UK£227.2b | UK£61.9b | UK£5.7b | 31.2x | 40.1x | 3.7x |
| Thu, 11 Nov 2021 | UK£245.0b | UK£59.2b | UK£7.5b | 25.7x | 32.8x | 4.1x |
| Sat, 09 Oct 2021 | UK£227.7b | UK£58.4b | UK£7.5b | 27.8x | 30.3x | 3.9x |
| Mon, 06 Sep 2021 | UK£230.1b | UK£58.1b | UK£7.5b | 30.3x | 30.7x | 4x |
| Wed, 04 Aug 2021 | UK£221.3b | UK£58.1b | UK£7.5b | 26.7x | 29.5x | 3.8x |
Price to Earnings Ratio
22.4x
Current Industry PE
- Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 28.3x which is lower than its 3-year average PE of 38.4x.
- The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 4.0% per year over the last three years.
- Revenues for these companies have grown 8.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 0.24% | |
| Healthcare | -0.33% | |
| Pharma | -0.28% | |
| Pharma | -0.28% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AZN AstraZeneca | UK£123.60 | 1.5% +UK£2.9b | 4.8% | PE38.5x | |
| REDX Redx Pharma | UK£0.15 | 62.2% +UK£22.4m | -53.8% | PS13.9x | |
| ANCR Animalcare Group | UK£2.44 | 8.4% +UK£12.0m | 34.1% | PE122.9x | |
| DPH Dechra Pharmaceuticals | UK£38.66 | 0.2% +UK£6.8m | 32.4% | PS5.8x | |
| AGY Allergy Therapeutics | UK£0.033 | 3.1% +UK£4.8m | n/a | PS3x |
